Published May 2023 | Version v1
Journal article

Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

Bacha, Rose Al
Bouhnik, Yoram
Serrero, Melanie
Filippi, Jerome
Roblin, Xavier
Bourrier, Anne
Bouguen, Guillaume
Franchimont, Denis
Savoye, Guillaume
Buisson, Anthony
Louis, Edouard
Nancey, Stephane
Abitbol, Vered
Reimund, Jean-Marie
Dewit, Olivier
Vuitton, Lucine
Mathieu, Nicolas
Peyrin-Biroulet, Laurent
Gilletta, Cyrielle
Allez, Matthieu
Viennot, Stephanie
Berre, Catherine Le
Laharie, David
Nachury, Maria
Amiot, Aurelien
Amiot, Aurelien
Tadbiri, Sara
Gagniere, Charlotte
Tannoury, Jenny
Pariente, Benjamin
Wils, Pauline
Bouhnik, Yoram
Stefanescu, Carmen
Treton, Xavier
Martins, Carole
Uzzan, Mathieu
Serrero, Melanie
Filippi, Jerome
Hébuterne, Xavier
Arab, Nadia
Cluzeau, Virginie
Roblin, Xavier
Tedesco, Emilie Del
Beaugerie, Laurent
Seksik, Philippe
Bourrier, Anne
Landmann, Cecilia
Kirchgesner, Julien
Sokol, Harry
Bouguen, Guillaume
Siproudhis, Laurent
Dewitte, Marie
Franchimont, Denis
Savoye, Guillaume
Buisson, Anthony
Louis, Edouard
Reenaers, Catherine
Nancey, Stephane
Boschetti, Gilles
Gay, Claire
Danion, Pauline
Flourié, Bernard
Abitbol, Vered
Malamut, Georgia
Reimund, Jean-Marie
Caron, Benedicte
Dewitt, Olivier
Vuitton, Lucine
Mathieu, Nicolas
Pestour, Sandie
Chateau, Thomas
Peyrin-Biroulet, Laurent
Zallot, Camille
Gilletta, Cyrielle
Allez, Matthieu
Gornet, Jean-Marc
Baudry, Clotilde
Viennot, Stephanie
Bourreille, Arnaud
Trang-Poisson, Caroline
Dib, Nina
Brixi, Hedi
Cadiot, Guillaume
Boualit, Medina
Painchart, Claire
Plastaras, Laurianne
Altwegg, Romain
Boivineau, Lucile
Fumery, Mathurin
Caillo, Ludovic
Laharie, David
Riviere, Pauline
Poullenot, Florian
Coffin, Benoit
Duboc, Henri
Nahon, Stephane
Tavernier, Noemie
Simon, Marion
Coulibaly, Baya
Amil, Morgane
Nicolas, Duveau
Khater, Sherine
Kaassis, Mehdi
Goutorbe, Felix
Moussata, Driffa
Picon, Laurence
Others:
Hôpital Beaujon [AP-HP] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Hôpital Nord [CHU - APHM]
Immunité muqueuse et vaccination ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA)
Service de Gastro-entérologie et Hépatologie [CHU Saint-Etienne] ; Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)
Centre de Recherche Saint-Antoine (CRSA) ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
Hôpital Erasme [Bruxelles] (ULB) ; Faculté de Médecine [Bruxelles] (ULB) ; Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)
CHU Clermont-Ferrand
Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre de Recherche en Nutrition Humaine d'Auvergne (CRNH d'Auvergne)-Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE)-Université Clermont Auvergne (UCA)
Centre Hospitalier Universitaire de Liège (CHU-Liège)
Hospices Civils de Lyon (HCL)
Voies de Signalisation du Développement et du Stress Cellulaire dans les Cancers Digestifs et Urologiques ; Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
Service de Gastro-Entérologie [CHRU Besançon] ; Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)
CHU Grenoble
Service d'Hépato-gastro-entérologie [CHRU Nancy] ; Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)
Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Hopital Saint-Louis [AP-HP] (AP-HP) ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
CHU Amiens-Picardie
Périnatalité et Risques Toxiques - UMR INERIS_I 1 (PERITOX) ; Institut National de l'Environnement Industriel et des Risques (INERIS)-Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie
Groupe d'Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)

Description

Background: In recent years, an increasing prevalence of obesity in inflammatory bowel disease (IBD) has been observed. However, only a few studies have focused on the impact of overweight and obesity on IBD-related disability.Aims: To identify the factors associated with obese and overweight patients with IBD, including IBD-related disability.Patients and methods: In this cross-sectional study, we included 1704 consecutive patients with IBD in 42 centres affiliated with the Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif (GETAID) using a 4-page questionnaire. Factors associated with obesity and overweight were assessed using univariate and multivariate analyses (odds ratios (ORs) are provided with 95% confidence intervals).Results: The prevalence rates of overweight and obesity were 24.1% and 12.2%, respectively. Multivariable analyses were stratified by age, sex, type of IBD, clinical remission and age at diagnosis of IBD. Overweight was significantly associated with male sex (OR = 0.52, 95% CI [0.39-0.68], p < 0.001), age (OR = 1.02, 95% CI [1.01-1.03], p < 0.001) and body image subscore (OR = 1.15, 95% CI [1.10-1.20], p < 0.001) (Table 2). Obesity was significantly associated with age (OR = 1.03, 95% CI [1.02-1.04], p < 0.001), joint pain subscore (OR = 1.08, 95% CI [1.02-1.14], p < 0.001) and body image subscore (OR = 1.25, 95% CI [1.19-1.32], p < 0.001) (Table 3).Conclusion: The increasing prevalence of overweight and obesity in patients with IBD is associated with age and poorer body image. A holistic approach to IBD patient care should be encouraged to improve IBD-related disability and to prevent rheumatological and cardiovascular complications.

Abstract

International audience

Additional details

Created:
June 3, 2023
Modified:
December 1, 2023